These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 13358822)
1. [The problem of BAL action in therapeutic insulin coma]. VOELKEL A Nervenarzt; 1956 Aug; 27(8):369. PubMed ID: 13358822 [No Abstract] [Full Text] [Related]
2. [2. Cases of coma following administration of barbiturate potentiated by autonomic drugs after insulin shock therapy]. VALLADE L; DANILLON P; POSTEL J Ann Med Psychol (Paris); 1955 Jun; 113 2(1):104-8. PubMed ID: 13238950 [No Abstract] [Full Text] [Related]
3. [Action of potassium in insulin coma and electroshock]. CICARDO VH; FONTANA AE C R Seances Soc Biol Fil; 1951 Mar; 145(5-6):434-6. PubMed ID: 14849088 [No Abstract] [Full Text] [Related]
4. The use of glucagon in the termination of therapeutic insulin coma. BRAUN M; PARKER M Am J Psychiatry; 1959 Mar; 115(9):814-5. PubMed ID: 13627263 [No Abstract] [Full Text] [Related]
5. Use of hyaluronidase in insulin coma. PARGITER RA Dis Nerv Syst; 1957 May; 18(5):194-5. PubMed ID: 13427658 [No Abstract] [Full Text] [Related]
6. [Insulin coma treatment and leucotomy today]. THELLE P Nord Med; 1960 Feb; 63():177-9. PubMed ID: 13837691 [No Abstract] [Full Text] [Related]
7. Use of whole protein supplement as an adjunct in insulin coma therapy. DEMOTT JD Am J Psychiatry; 1955 Apr; 111(10):774-5. PubMed ID: 14361764 [No Abstract] [Full Text] [Related]
8. [The cause of coma during insulin shock. Study based on change of extracellular fluid volume]. OZAYDIN S Encephale; 1962; 51():383-94. PubMed ID: 13940897 [No Abstract] [Full Text] [Related]
9. [Mechanism of action of panthothenic acid in insulin shock therapy]. VOELKEL A Arch Int Pharmacodyn Ther; 1956 Sep; 107(3-4):271-4. PubMed ID: 13363499 [No Abstract] [Full Text] [Related]
10. Measurements of effects of hyaluronidase in insulin coma treatment. SCHMIDT KE; TONG J J Ment Sci; 1958 Oct; 104(437):1136-48. PubMed ID: 13621159 [No Abstract] [Full Text] [Related]
11. [Interruption of therapeutic insulin coma with glucagon]. HANZLICEK L Cesk Psychiatr; 1960 Apr; 56():130-3. PubMed ID: 13851904 [No Abstract] [Full Text] [Related]
12. Use of hyaluronidase in insulin coma therapy. HOLDEN JC; MCGUINNESS OL Br Med J; 1957 Jul; 2(5036):85-6. PubMed ID: 13436864 [No Abstract] [Full Text] [Related]
13. [The influence of metabolism-active substances on therapeutic insulin coma]. FUENFGELD EW Nervenarzt; 1960 Jan; 31():33-6. PubMed ID: 13825545 [No Abstract] [Full Text] [Related]
14. Useful adjuncts in insulin coma therapy. WEISS DM Am J Psychiatry; 1954 Apr; 110(10):784. PubMed ID: 13138760 [No Abstract] [Full Text] [Related]
15. Insulin coma in decline. BOURNE H Am J Psychiatry; 1958 May; 114(11):1015-7. PubMed ID: 13533629 [No Abstract] [Full Text] [Related]
16. [Cocarboxylase in insulin shock therapy]. POROT M Ann Med Psychol (Paris); 1955 Jun; 113 2(1):13-5. PubMed ID: 13238929 [No Abstract] [Full Text] [Related]
17. [Considerations on the facilitating action of hyaluronidase in insulin coma]. SACERDOTI G Rass Studi Psichiatr; 1951; 40(2):299-308. PubMed ID: 14854269 [No Abstract] [Full Text] [Related]
18. Use of glucagon in insulin coma therapy. LAQUEUR HP; LA BURT HA Dis Nerv Syst; 1961 Apr; 22(4)Suppl():112-4. PubMed ID: 13759068 [No Abstract] [Full Text] [Related]
19. [Protective action of belladonna on cardiocirculatory disorders in insulin shock]. CUPPINI R; CAROTTI A Atti Soc Ital Cardiol; 1956; 1():379-81. PubMed ID: 13328714 [No Abstract] [Full Text] [Related]